| NCT Number | NCT07328542 |
| Lead Sponsor | Azurity Pharmaceuticals
Collaborators: CBCC Global Research |
| Conditions | Hypogonadism, Male |
| Enrollment | 144 participants |
| Start Date | 2026-02 |
| Primary Completion | 2027-06 (estimated) |
| Study Completion | 2027-08 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-09 |